Act as a World-Class Professor of General Medicine, Clinical Pharmacology, Pathology, and Medical Education. Teach me Malaria disease in a simple, exam-oriented, and clinically practical manner. For every disease, follow this format: 1. Definition - One-line exam definition - Simple explanation 2. Causes (Etiology) - Common causes - Important risk factors 3. Types / Classification - Brief explanation of each type 4. Pathophysiology - Step-by-step flowchart with arrows - Easy to understand 5. Clinical Features - Symptoms - Signs - Explain why important symptoms occur 6. Key Symptoms That Suggest the Diagnosis - Hallmark symptom - Classic clinical clues - Red flag findings
"malaria" AND "clinical features" AND "pathophysiology"
| Species | Type of Malaria | Severity |
|---|---|---|
| P. falciparum | Malignant tertian (falciparum) | Most dangerous - HIGH fatality |
| P. vivax | Benign tertian | Moderate - can relapse |
| P. ovale | Benign tertian | Mild - can relapse |
| P. malariae | Quartan malaria | Mild - chronic |
| P. knowlesi | Simian/zoonotic | Moderate-severe (misidentified as P. malariae) |
Exam tip: P. falciparum is responsible for almost all malaria deaths. P. knowlesi (Southeast Asia) looks like P. malariae on smear but behaves like falciparum.
| Risk Factor | Reason |
|---|---|
| Travel to/residence in endemic zones (sub-Saharan Africa, Southeast Asia, South Asia, Central/South America) | Exposure to infected mosquitoes |
| No chemoprophylaxis taken | Loss of preventive protection |
| No bed nets or repellent use | Direct vector exposure |
| Children < 5 years | Immature immunity |
| Pregnant women | Immunosuppression + placental sequestration |
| Non-immune travelers | No prior partial immunity |
| Sickle cell trait (HbS heterozygous) | Protective against severe disease |
| Asplenia | Loss of red cell filtering - worse disease |
Exam pearl: Sickle cell trait, thalassemia, G6PD deficiency, and other red cell defects are most prevalent in malaria-endemic regions because heterozygous states confer protection from severe malaria - a classic example of balanced polymorphism.
| Species | Fever Cycle | Type |
|---|---|---|
| P. falciparum | 48 hours | Tertian |
| P. vivax | 48 hours | Tertian |
| P. ovale | 48 hours | Tertian |
| P. malariae | 72 hours | Quartan |
| P. knowlesi | 24 hours | Quotidian |

Female Anopheles mosquito bites human
↓
SPOROZOITES injected into bloodstream
↓
Sporozoites travel to LIVER within minutes
(bind via Thrombospondin-related adhesive protein +
Circumsporozoite protein → Heparan sulfate proteoglycan on hepatocytes)
↓
HEPATIC STAGE (clinically silent - 1-4 weeks incubation)
→ Sporozoites → differentiate into MEROZOITES inside hepatocytes
→ [P. vivax / P. ovale only: some form HYPNOZOITES = dormant stage → causes relapse later]
↓
Infected hepatocytes RUPTURE → release thousands of MEROZOITES into blood
↓
ERYTHROCYTIC STAGE begins (causes all clinical disease)
→ Merozoite surface lectin-like molecule binds GLYCOPHORIN (sialidated)
on RBC surface → merozoite invaginates into RBC inside a "digestive vacuole"
↓
Inside RBC: Merozoite → RING TROPHOZOITE → TROPHOZOITE → SCHIZONT
↓
SCHIZONT expresses PfEMP1 (P. falciparum erythrocyte membrane protein 1)
→ PfEMP1 forms KNOBS on RBC surface
→ Knobs bind endothelial adhesion molecules: ICAM-1, VCAM-1, CD36
→ Infected RBCs SEQUESTER in capillary beds (brain, lung, kidney, placenta)
→ This causes CEREBRAL MALARIA, ARDS, renal failure
↓
Schizonts → differentiate into MEROZOITES → RBC LYSES (every 48 or 72 hrs)
→ Merozoites released → infect new RBCs (cycle repeats)
→ RBC lysis triggers fever (TNF-α, IL-1, IL-6 release)
→ Hemozoin (brown malarial pigment = hemoglobin breakdown product) released
↓
Some trophozoites → GAMETOCYTES → ingested by next mosquito → sexual cycle restarts
| Manifestation | Mechanism |
|---|---|
| Cyclical fever | Synchronized RBC lysis releases merozoites + pyrogens (TNF-α, IL-1) |
| Hemolytic anemia | Destruction of parasitized RBCs + innocent bystander lysis |
| Splenomegaly | Hyperplasia of mononuclear phagocytes clearing parasitized RBCs; hemozoin deposition |
| Hepatomegaly | Same mechanism + hemozoin deposits in liver |
| Thrombocytopenia | Splenic sequestration + immune-mediated platelet destruction |
| Cerebral malaria | PfEMP1-mediated RBC sequestration in cerebral microvasculature → obstruction + inflammation |
| Blackwater fever | Massive intravascular hemolysis → hemoglobinemia + hemoglobinuria |
| Renal failure | Hemoglobinuria, hypovolemia, immune complex deposition, direct tubular toxicity |
| ARDS | Sequestration of RBCs in pulmonary microvasculature + inflammatory cytokines |
COLD STAGE (15-60 min)
→ Rigors (violent shaking chills), goose bumps, teeth chattering
→ Temperature RISING
↓
HOT STAGE (2-6 hours)
→ High fever (39-41°C / 102-106°F)
→ Flushing, headache, nausea, vomiting, body aches
→ No sweating yet
↓
SWEATING STAGE (2-4 hours)
→ Profuse sweating, temperature FALLS
→ Patient feels exhausted but better temporarily
→ Cycle repeats in 48 or 72 hours
| Symptom | Notes |
|---|---|
| Fever (cyclic paroxysms) | Hallmark - but early falciparum may be irregular/continuous |
| Chills and rigors | Especially at start of paroxysm |
| Headache | Common, can be severe |
| Myalgia and arthralgia | Generalized body aches |
| Nausea, vomiting, diarrhea | Can mimic gastroenteritis |
| Fatigue and malaise | Constant |
| Cough | Can occur; ARDS in severe cases |
| Sign | Notes |
|---|---|
| Fever | High, may be intermittent |
| Splenomegaly | Characteristic - "Tropical splenomegaly"; can be massive in chronic cases |
| Pallor | Due to hemolytic anemia |
| Jaundice | Hemolytic (unconjugated hyperbilirubinemia) |
| Hepatomegaly | Tender liver enlargement |
| Thrombocytopenia | Very common - platelets often <150,000 |
| Severe Feature | Clinical Presentation | Mechanism |
|---|---|---|
| Cerebral malaria | Altered consciousness, seizures, coma | Microvessel sequestration in brain |
| Blackwater fever | Dark/black urine (hemoglobinuria) | Massive intravascular hemolysis |
| Severe anemia | Hb < 7 g/dL | RBC destruction |
| ARDS | Respiratory distress, bilateral lung opacities on CXR | Pulmonary sequestration + cytokines |
| Acute kidney injury | Oliguria/anuria, rising creatinine | Hemoglobinuria + sequestration |
| Hypoglycemia | Confusion, seizures | Parasite consumes glucose + quinine stimulates insulin |
| Circulatory collapse | Shock (algid malaria) | Dehydration + sepsis |
| Hyperparasitemia | >5% parasitized RBCs | Massive infection load |
| Abnormal bleeding | DIC | Coagulation cascade activation |
Cyclical paroxysms of chills → fever → profuse sweating in a patient from or traveling to an endemic area.
| Clue | What It Suggests |
|---|---|
| Fever every 48 hours | P. falciparum, P. vivax, or P. ovale |
| Fever every 72 hours | P. malariae (quartan) |
| Travel history to Africa, South Asia, Southeast Asia, or Latin America | Endemic exposure |
| No malaria prophylaxis taken | Unprotected exposure |
| Fever + splenomegaly + anemia + thrombocytopenia | Classic triad - think malaria first |
| Dark cola-colored urine (hemoglobinuria) + jaundice + severe anemia | Blackwater fever (P. falciparum) |
| Fever returning months or years after travel | Relapse from hypnozoites (P. vivax or P. ovale) |
| Nephrotic syndrome in a child from endemic region | P. malariae nephropathy |
| Seizures + coma in febrile patient from Africa | Cerebral malaria (P. falciparum) until proven otherwise |
| Blood smear: "banana-shaped gametocytes" | P. falciparum - pathognomonic |
| Blood smear: "Schuffner's dots" in enlarged RBCs | P. vivax or P. ovale |
| Blood smear: "Maurer's clefts" + ring forms only | P. falciparum (late forms sequestered, not seen in blood) |
Clinical pearl: In falciparum malaria, peripheral smear may show ONLY ring forms and gametocytes - all other stages are sequestered in deep microvasculature and invisible on blood film. This is why very low parasitemia on smear does NOT rule out severe falciparum malaria.
Protective genetics pearl (from Murray & Nadel): Nearly all genetic RBC defects - sickle cell anemia, thalassemia, pyruvate kinase deficiency, G6PD deficiency - are most prevalent in malaria-endemic regions. Heterozygous sickle cell trait is protective against severe falciparum malaria. This is textbook balanced polymorphism.
| Feature | P. falciparum | P. vivax | P. malariae | P. knowlesi |
|---|---|---|---|---|
| Fever cycle | 48h (irregular early) | 48h | 72h | 24h |
| RBCs infected | All ages | Young | Old | All |
| Hypnozoites (relapse) | No | Yes | No | No |
| Severity | Severe/fatal | Moderate | Mild/chronic | Moderate-severe |
| Unique feature | Cerebral malaria, blackwater fever | Most common globally | Nephrotic syndrome | Zoonotic from monkeys |
| Blood smear hallmark | Banana gametocytes, Maurer's clefts, ring forms | Schuffner's dots, enlarged RBCs | Small RBCs, band trophozoites | Resembles P. malariae |
7. Laboratory Investigations of Malaria disease Create a table: Investigation | Expected Finding | Clinical Significance Include: - CBC - Biochemistry - Disease-specific tests - Imaging findings if relevant 8. Differential Diagnosis Create a comparison table: Disease | Similar Features | Differentiating Features 9. Short Clinical Case Example format: "A 55-year-old male presents with chest pain radiating to the left arm, sweating, and breathlessness. ECG shows ST elevation in leads II, III, and aVF. Troponin-I is elevated." Diagnosis: Reasoning: Provide only 1–2 short high-yield cases.
| Investigation | Expected Finding | Clinical Significance |
|---|---|---|
| Hemoglobin (Hb) | Decreased - normochromic, normocytic anemia | Hemolytic destruction of parasitized RBCs + bystander lysis of uninfected RBCs + inhibited erythropoietin response |
| Total Leukocyte Count (TLC) | Normal or mildly decreased (leukopenia) | Atypical for most bacterial infections - helps point away from bacterial sepsis; leukocytosis suggests secondary bacterial infection |
| Platelets | Thrombocytopenia (often <150,000; may be severely low) | Splenic sequestration + immune-mediated destruction; thrombocytopenia is one of the most consistent CBC findings in malaria |
| MCV / RBC morphology | Normocytic; target cells may be seen | Reflects hemolytic process; RBC morphology on smear identifies species |
| Reticulocyte count | Low/inappropriately normal despite anemia | Erythropoietin suppression by parasite; blunted compensatory response |
| Peripheral blood smear (Giemsa/Wright stain) | Ring trophozoites, schizonts, gametocytes within RBCs | Gold standard for diagnosis - allows species identification and parasite density estimation |
Exam tip: Thrombocytopenia + normocytic anemia + fever in a traveler = malaria until proven otherwise.
| Investigation | Expected Finding | Clinical Significance |
|---|---|---|
| Serum bilirubin (Total + Indirect) | Elevated; predominantly unconjugated (indirect) | Hemolysis releases Hb → unconjugated bilirubin rises; jaundice is hemolytic in nature |
| LDH (Lactate Dehydrogenase) | Markedly elevated | Marker of hemolysis and cell destruction; also used in RDTs (plasmodial LDH) |
| Serum transaminases (AST/ALT) | Mildly to moderately elevated | Hepatocyte involvement from hemozoin deposition; rarely severe unless coinfection |
| Serum creatinine / BUN | Elevated in severe/falciparum malaria | Indicates acute kidney injury (AKI) from hemoglobinuria, hypovolemia, microvessel sequestration |
| Blood glucose | Hypoglycemia (severe falciparum malaria) | Parasite consumes glucose directly + quinine/quinidine stimulate excess insulin secretion; a medical emergency - may cause seizures and coma |
| Serum electrolytes | Hyponatremia common; electrolyte disturbances | From fluid shifts, vomiting, sweating, and inappropriate ADH secretion |
| Arterial blood gas / Lactate | Metabolic acidosis; elevated lactate | Tissue hypoperfusion from anemia and microvessel obstruction; high lactate = severe disease and poor prognosis |
| Coagulation profile (PT, aPTT, fibrinogen, D-dimer) | Deranged in severe disease | DIC in falciparum malaria - prolonged PT/aPTT, low fibrinogen, elevated D-dimer |
| ESR | Elevated | Non-specific marker of inflammation |
| Urinalysis | Hemoglobinuria (dark/black urine) in severe cases | Blackwater fever - massive intravascular hemolysis → free Hb in urine; predicts renal failure |
| Serum haptoglobin | Decreased | Consumed by free hemoglobin from hemolysis - confirms hemolytic process |
| Investigation | Expected Finding | Clinical Significance |
|---|---|---|
| Thick blood smear (Giemsa stain) | Parasitized RBCs; parasite count per WBC | Gold standard. One drop of blood, dried on slide. Most sensitive for detecting parasites even at low density. Standard in endemic areas. Done in triplicate over 12-24h if first smear negative |
| Thin blood smear (Giemsa/Wright stain) | Intraerythrocytic morphology visible | Species identification; RBC size changes and inclusions are seen. Preferred where malaria is uncommon and lab expertise is available |
| Rapid Diagnostic Test (RDT) | Detects parasite antigens: HRP-2 (falciparum-specific), pLDH and aldolase (all species) | Qualitative, results in 15-20 minutes. FDA-approved (BinaxNOW). Does NOT replace microscopy for species ID or density. HRP-2 false negatives exist in parts of South America and Horn of Africa where P. falciparum lacks the HRP-2 gene |
| PCR (Molecular assay) | Species-specific DNA amplification; detects even sub-microscopic parasitemia | Most sensitive and specific; distinguishes all 5 species including P. knowlesi. Not practical for routine use (time, cost, logistics). Used in reference labs and research |
| Serology (IgG/IgM antibodies) | Elevated malaria antibody titers | Slow to develop; persists for months-years. NOT useful for acute diagnosis. Used for epidemiological surveys and blood donor screening |
| Parasite density / Parasitemia % | >5% parasitized RBCs = severe malaria (WHO criterion) | Hyperparasitemia is a WHO severity criterion and indicates urgent parenteral treatment; in falciparum, late-stage parasites are sequestered and smear underestimates true burden |
| Investigation | Expected Finding | Clinical Significance |
|---|---|---|
| Chest X-ray (CXR) | Diffuse bilateral symmetric opacities (pulmonary edema pattern); lobar consolidation; pleural effusions in severe cases | Indicates malaria-associated ARDS (acute lung injury). Children and pregnant women most affected. Alveolar macrophages may contain hemozoin on BAL |
| Ultrasound abdomen | Splenomegaly (often massive); hepatomegaly; free fluid in severe disease | Confirms tropical splenomegaly; monitor for splenic rupture (most dangerous with P. vivax) - presents as sudden severe LUQ pain with hemodynamic collapse |
| CT Brain / MRI Brain | In cerebral malaria: petechial hemorrhages, diffuse cerebral edema, white matter changes | Indicates severe P. falciparum microvessel sequestration and cerebral ischemia |
| Feature | P. falciparum | P. vivax | P. ovale | P. malariae |
|---|---|---|---|---|
| RBC size | Normal/small | Enlarged | Enlarged, oval | Normal/small |
| Inclusions | Maurer's clefts | Schuffner's dots | Schuffner's dots | Ziemann's dots |
| Gametocyte shape | Banana/crescent (pathognomonic) | Round | Round | Round |
| Stages visible on smear | Ring forms only (schizonts sequestered) | All stages | All stages | All stages |
| Multiple rings/cell | Common (appliqué/accolé form) | Rare | Rare | Rare |
| Disease | Similar Features to Malaria | Differentiating Features |
|---|---|---|
| Typhoid fever (Salmonella typhi) | Prolonged fever, headache, hepatosplenomegaly, thrombocytopenia, travel history to endemic area | Fever is "step-ladder" pattern; relative bradycardia (Faget's sign); rose spots on trunk; positive Widal test / blood/stool culture; no cyclic paroxysms; no hemolytic anemia |
| Dengue fever | Fever, thrombocytopenia, headache, myalgia, travel to tropics | Classic "breakbone" pain (severe retro-orbital headache + severe myalgia); maculopapular rash; leukopenia more pronounced; positive NS1 antigen / dengue IgM; no splenomegaly in early disease; no blood smear parasites |
| Visceral Leishmaniasis (Kala-azar) | Prolonged fever, massive splenomegaly, anemia, weight loss, travel to endemic area | Very gradual onset over months; marked weight loss (cachexia); hyperpigmentation of skin; hypergammaglobulinemia; positive rK39 RDT / bone marrow smear for Leishman-Donovan bodies; no cyclic fever |
| Leptospirosis | Fever, chills, myalgia, jaundice, renal involvement, headache | Biphasic fever with "Weil's disease" (jaundice + AKI + hemorrhage); prominent calf muscle tenderness; conjunctival suffusion; uveitis; exposure to water/animals; positive MAT / IgM ELISA; no parasites on smear |
| Enteric (Typhoid) fever | Fever, splenomegaly, abdominal pain, headache | As above - see typhoid row |
| Bacterial Sepsis | High fever, chills, rigors, organ dysfunction | Leukocytosis (high TLC) rather than leukopenia; positive blood cultures; usually no splenomegaly or hemolytic anemia; no travel history; negative blood smear |
| Meningitis / Encephalitis | Fever, altered consciousness, seizures, headache (cerebral malaria mimics) | Meningism (neck stiffness, Kernig's/Brudzinski's signs); CSF analysis diagnostic; no parasitemia on blood smear; no hemolytic anemia; no travel history needed |
| Viral Hemorrhagic Fevers (Ebola, Dengue, Yellow Fever) | Fever, thrombocytopenia, hemorrhage, organ failure in travelers from endemic areas | All patients should have malaria smear done first (Rosen's); specific viral PCR/serology; different epidemiological exposure (Ebola = contact with infected body fluids) |
| Babesiosis | Fever, hemolytic anemia, thrombocytopenia, intraerythrocytic parasites on smear - the closest mimic | Exposure to tick bites in northeastern USA/New England (not mosquito); "Maltese cross" (tetrad) forms on smear (pathognomonic); no Schüffner's dots; positive Babesia PCR/serology; no travel to tropics required |
| Autoimmune Hemolytic Anemia (AIHA) | Hemolytic anemia, jaundice, splenomegaly, thrombocytopenia | Positive direct Coombs (DAT) test; no fever or travel history; no parasites on smear; may follow viral illness or drug exposure |
| Blackwater fever vs. Hemoglobinuria from other causes | Dark/black urine, hemolytic anemia, renal failure | Blackwater fever is specifically in the context of P. falciparum infection or quinine use; other causes include G6PD deficiency triggered by oxidant drugs, March hemoglobinuria, paroxysmal nocturnal hemoglobinuria (PNH) |
| Acute Schistosomiasis (Katayama fever) | Fever, eosinophilia, hepatosplenomegaly, travel to Africa/Asia | Marked eosinophilia (key differentiator); urticaria; exposure to fresh water; positive schistosoma serology; ova in urine/stool |
Key exam principle: In any febrile traveler returning from sub-Saharan Africa or South/Southeast Asia, malaria is the presumptive diagnosis until ruled out by at least three negative blood smears taken 12-24 hours apart. Do not wait for smear results before treating if clinical suspicion is high - P. falciparum kills within days.
Exam memory hook: "The 3 H's of severe falciparum malaria" = Hypoglycemia + Hyperparasitemia + Hemolysis (anemia) + one bonus - Headache progressing to coma (cerebral malaria).
10. Treatment Of Malaria A. Non-Pharmacological Treatment B. Pharmacological Treatment Create a table: Drug | Drug Group | Mechanism of Action | Indication | Dose | Major Adverse Effects For every disease mention: - Drug of Choice (DOC) - First-line drugs - Alternative drugs - Emergency drugs (if applicable) 11. Clinical Pearls - Important bedside clues - High-yield exam facts - Viva points 12. Common Diagnostic Mistakes - Frequently missed findings - Common confusion with other diseases - How to avoid errors
| Intervention | Details | Rationale |
|---|---|---|
| Hospitalization | All suspected P. falciparum cases should be admitted - even if initially appear "uncomplicated." Severe malaria requires ICU-level care | Falciparum can deteriorate rapidly within hours of presentation; early organ failure must be detected |
| Strict bed rest | Enforce during febrile paroxysm | Reduces metabolic demand; prevents falls during rigor/seizure episodes |
| Oral hydration | Adequate fluid intake in uncomplicated cases | Counters dehydration from sweating and vomiting; prevents AKI |
| IV fluid management (severe cases) | Careful IV fluids - avoid fluid overload | Pulmonary edema risk is high in falciparum; overhydration can worsen ARDS. Fluid balance must be monitored strictly |
| Antipyretics | Paracetamol (acetaminophen) 500 mg every 6 hours | Controls fever and rigors; reduces discomfort. Avoid NSAIDs in thrombocytopenic patients |
| Blood glucose monitoring | Frequent glucose checks (especially in severe falciparum, pregnant women, patients on quinine) | Hypoglycemia is a life-threatening emergency; quinine stimulates insulin release; parasite consumes glucose |
| IV glucose (if hypoglycemic) | 50% dextrose IV bolus, then 10% dextrose maintenance | Immediately corrects hypoglycemia that may be driving coma/seizures |
| Blood transfusion | Indicated for Hb < 7 g/dL (severe anemia) or Hb < 10 g/dL with respiratory distress | Severe hemolytic anemia causes cardiovascular compromise; transfusion is life-saving, especially in children |
| Airway management | Intubation for cerebral malaria with GCS ≤ 8 | Protect airway; prevent aspiration; manage raised ICP |
| Seizure control | Benzodiazepines (diazepam/lorazepam) for active seizures | Cerebral malaria-associated seizures are common and must be treated aggressively |
| Mosquito net + insecticide | Permethrin-treated bed nets | Prevents reinfection and further transmission; core public health measure |
| Isolation from mosquitoes | Barrier nursing; avoid further mosquito bites while gametocytemic | Prevents transmission to other Anopheles mosquitoes during treatment |
| Nutritional support | High-calorie diet once tolerated | Malaria causes significant catabolism; nutritional support aids recovery |
| Monitor for complications | Urine output, creatinine, glucose, neuro status q4-6h | Early detection of AKI, ARDS, DIC, cerebral malaria progression |
Adjunctive treatments that are NOT recommended (per Harrison's): High-dose corticosteroids, heparin, dextran, urea, desferrioxamine, anti-TNF antibody - all have been studied and found ineffective or harmful in severe malaria. Do NOT use steroids in cerebral malaria.
| Drug | Drug Group | Mechanism of Action | Indication | Dose | Major Adverse Effects |
|---|---|---|---|---|---|
| 🥇 Artemether + Lumefantrine (Coartem) | Artemisinin combination therapy (ACT) | Artemether: endoperoxide bridge cleaved by heme iron → free radicals → oxidative stress kills parasite. Lumefantrine: inhibits β-hematin formation + fatty acid synthesis in parasite | DOC - Uncomplicated P. falciparum (chloroquine-resistant); also follow-on oral therapy after IV artesunate | Adults (>35 kg): 4 tablets (artemether 20 mg / lumefantrine 120 mg) twice daily × 3 days (6 doses total; first 2 doses 8h apart) | Nausea, vomiting, diarrhea; QTc prolongation (mild); headache; dizziness; hypersensitivity rash |
| 🥇 Artesunate + Amodiaquine | ACT | Artesunate: same as above. Amodiaquine: 4-aminoquinoline, blocks hemozoin formation | DOC alternative ACT - Uncomplicated P. falciparum | 2 adult tablets once daily × 3 days | Agranulocytosis with amodiaquine (rare but serious); nausea |
| 🥈 Atovaquone + Proguanil (Malarone) | Quinone + folate antagonist combination | Atovaquone: inhibits mitochondrial electron transport (cytochrome bc1 complex) → collapses mitochondrial membrane potential. Proguanil: inhibits dihydrofolate reductase (DHFR) → blocks folate synthesis | Uncomplicated P. falciparum (chloroquine-resistant); also chemoprophylaxis. Ideal for travelers | Adults: 4 adult tablets once daily × 3 days (with food or milk) | Nausea, vomiting, abdominal pain, headache; NOT for use in severe renal impairment |
| 🥈 Quinine + Doxycycline | Quinoline methanol + Tetracycline | Quinine: blocks hemozoin crystallization; intercalates DNA. Doxycycline: inhibits protein synthesis (30S ribosomal subunit) | Uncomplicated P. falciparum where ACT not available; chloroquine-resistant P. falciparum | Quinine sulfate 650 mg PO q8h × 3-7 days PLUS Doxycycline 100 mg PO twice daily × 7 days | Quinine: cinchonism (tinnitus, headache, nausea, visual disturbance, deafness); hypoglycemia; cardiac arrhythmia; hypotension. Doxycycline: photosensitivity; GI upset; esophageal ulceration; avoid in pregnancy and children <8 yrs |
| 🥈 Mefloquine | Quinoline methanol | Similar to quinine - accumulates in parasite food vacuole, disrupts hemozoin crystallization | Uncomplicated chloroquine-resistant P. falciparum; chemoprophylaxis | 750 mg PO loading dose, then 500 mg PO 6-12h later (total 1250 mg in 2 doses) | Severe neuropsychiatric effects - anxiety, vivid nightmares, psychosis, seizures, hallucinations; cardiac arrhythmia (avoid in epilepsy, psychiatric illness, cardiac conduction defects) |
| Drug | Drug Group | Mechanism of Action | Indication | Dose | Major Adverse Effects |
|---|---|---|---|---|---|
| 🥇 Chloroquine phosphate | 4-Aminoquinoline | Concentrates in parasite food vacuole → inhibits heme polymerization → heme accumulates → toxic to parasite | DOC - Uncomplicated P. falciparum (sensitive strains only); ALL non-falciparum species (P. vivax, P. malariae, P. ovale, P. knowlesi) | 600 mg base PO, then 300 mg base at 6, 24, and 48h (total 1500 mg base over 3 days) | Pruritus (especially in Africans); nausea; headache; blurred vision; with prolonged use: retinopathy (irreversible), cardiomyopathy, myopathy. Avoid overdose - cardiac toxicity |
| Drug | Drug Group | Mechanism of Action | Indication | Dose | Major Adverse Effects |
|---|---|---|---|---|---|
| 🌿 Primaquine phosphate | 8-Aminoquinoline | Interferes with mitochondrial electron transport in parasite's liver stage; active against hypnozoites AND gametocytes | Radical cure of P. vivax and P. ovale (eliminates dormant liver hypnozoites to prevent relapse); also gametocytocidal for P. falciparum (reduces transmission) | 15 mg base (30 mg salt) PO once daily × 14 days (with food to reduce GI side effects) | Hemolytic anemia in G6PD-deficient patients - MUST check G6PD status before use; methemoglobinemia; nausea; abdominal cramps. Contraindicated in pregnancy (G6PD status of fetus unknown) |
| 🌿 Tafenoquine | 8-Aminoquinoline | Same mechanism as primaquine; longer half-life | Radical cure of P. vivax - single dose alternative to 14-day primaquine | 300 mg PO single dose (in chloroquine-sensitive P. vivax: given with chloroquine) | Same hemolytic risk in G6PD deficiency - G6PD testing mandatory before use; psychiatric effects (anxiety, insomnia, suicidal ideation reported) |
Principle: IV artesunate is superior to quinine - reduces mortality by 35% in Asian adults and 22.5% in African children vs. quinine (Harrison's). It is now the WHO gold-standard for severe malaria.
| Drug | Drug Group | Mechanism of Action | Indication | Dose | Major Adverse Effects |
|---|---|---|---|---|---|
| 🚨🥇 Artesunate IV | Artemisinin derivative (water-soluble) | Endoperoxide bridge cleaved by intraparasitic heme iron → free radical oxidative damage → rapid parasite killing across all erythrocytic stages. Acts on ring, trophozoite, and schizont stages. Also reduces cytoadherence of infected RBCs | DRUG OF CHOICE - Severe/complicated falciparum malaria; patients unable to take oral medications | 2.4 mg/kg IV stat (children <20 kg: 3 mg/kg), then 2.4 mg/kg at 12h and 24h, then once daily until able to take oral treatment. Follow with full oral ACT course | Thrombocytopenia; hemolytic anemia (post-artesunate delayed hemolysis - can occur 2-3 weeks after treatment); elevated liver enzymes; hyperbilirubinemia; rare hypersensitivity |
| 🚨🥈 Artemether IM | Artemisinin derivative (oil-based) | Same mechanism as artesunate. Oil-based → erratic absorption; inferior to IV artesunate | Severe malaria when IV artesunate NOT available | 3.2 mg/kg IM stat, then 1.6 mg/kg IM once daily | Similar to artesunate; erratic absorption reduces reliability; injection site reactions |
| 🚨🥈 Quinine IV (now 3rd-line) | Quinoline methanol | Blocks hemozoin formation; also active against schizonts and gametocytes of non-falciparum species | Severe malaria when artesunate not available; ALSO used COMBINED with artesunate in confirmed or suspected artemisinin-resistant zones | Loading dose: 20 mg/kg salt IV infused over 4h; then 10 mg/kg over 2-8h every 8h until able to take oral | Cinchonism (tinnitus, deafness, visual disturbance, nausea); hypoglycemia (insulin release stimulation) - critical; cardiac arrhythmia, QTc prolongation; hypotension if infused too fast; avoid in prior quinine use in last 24h |
After parenteral treatment: Switch to full course of oral ACT (artemether-lumefantrine or atovaquone-proguanil) as soon as patient can swallow. Add primaquine/tafenoquine if P. vivax or P. ovale (after G6PD check).
| Drug | Regimen | Notes |
|---|---|---|
| Atovaquone-proguanil (Malarone) | 1 adult tablet daily; start 1-2 days before, continue 7 days after travel | Best tolerated; excellent for short trips; expensive |
| Doxycycline | 100 mg daily; start 1-2 days before, continue 4 weeks after | Cheap; also protects against rickettsial diseases; photosensitivity common; not in pregnancy/children <8 yrs |
| Mefloquine | 250 mg weekly; start 2 weeks before, continue 4 weeks after | Neuropsychiatric side effects limit use; avoid in cardiac/psychiatric patients |
| Chloroquine | 300 mg base weekly; 1-2 weeks before, 4 weeks after | Only for chloroquine-sensitive areas (Central America, Caribbean) |
| Primaquine | 30 mg base daily; 1-2 days before, 7 days after | Also eliminates exoerythrocytic stages; G6PD check mandatory |
| Mistake | Why It Happens | How to Avoid It |
|---|---|---|
| "Only one negative smear rules out malaria" | Single smear misses low-density parasitemia, especially early in infection | Always repeat smear 3 times over 24-48h before excluding malaria. Treat if clinical suspicion is high regardless |
| Diagnosing "viral fever" or "influenza" in a returning traveler | Malaria symptoms (fever, myalgia, headache, GI upset) are non-specific and easily attributed to flu | Any febrile illness within 3 months of travel to endemic area = malaria until proven otherwise. Ask travel history on every febrile patient |
| Missing falciparum because parasitemia appears "low" | Mature P. falciparum stages are sequestered - peripheral blood smear underestimates true parasite burden | Low parasitemia on smear NEVER excludes severe falciparum. Clinical condition, not smear density alone, determines severity |
| Confusing malaria with typhoid fever | Both cause fever + splenomegaly + GI symptoms + thrombocytopenia | Typhoid has step-ladder fever, relative bradycardia, rose spots, no hemolytic anemia, no cyclic paroxysms. Send both blood culture AND blood smear |
| Confusing malaria with dengue fever | Both cause fever + thrombocytopenia + myalgia + travel history | Dengue: severe retro-orbital headache + maculopapular rash + leukopenia + no splenomegaly early. Send NS1 antigen and dengue IgM alongside malaria smear |
| Mistaking P. knowlesi for P. malariae on smear | Both have morphologically similar band/elongate trophozoites | P. knowlesi has 24-hour fever cycle (not 72h) and behaves clinically like severe falciparum. Southeast Asia exposure = send PCR to distinguish. Never dismiss a "P. malariae-looking" smear from Southeast Asia as benign |
| Using RDT alone without follow-up smear | RDT is quick but cannot estimate parasitemia or identify stage/species accurately | A positive RDT must always be followed by thick and thin blood smear for species ID and parasite density |
| Missing HRP-2-negative falciparum | P. falciparum strains in parts of South America and Horn of Africa have deleted HRP-2 gene → false negative HRP-2-based RDTs | If high clinical suspicion in a traveler from these regions with negative HRP-2 RDT → still do blood smear and PCR |
| Giving steroids for cerebral malaria | Intuitive to treat brain swelling with dexamethasone | Steroids are contraindicated - clinical trials showed increased mortality and complications. This is a life-threatening error |
| Skipping G6PD testing before primaquine | Urgency to prevent relapse | G6PD deficiency causes life-threatening hemolytic anemia with primaquine and tafenoquine. Always check G6PD status before prescribing |
| Treating P. falciparum with chloroquine in resistant areas | Chloroquine is cheap, familiar, and historically used | Chloroquine resistance is now near-universal for P. falciparum worldwide except a few areas (Central America, Caribbean). Always use ACT unless confirmed sensitive area |
| Failing to add primaquine after treating P. vivax | Treating only the blood stage seems sufficient as patient improves | Without primaquine, liver hypnozoites persist → relapse occurs weeks-months later. Always complete radical cure after confirming G6PD status |
| Diagnosing "gastroenteritis" when diarrhea and vomiting dominate | Malaria can present with prominent GI symptoms, especially in children | Include malaria in differential of any tropical febrile diarrheal illness, especially with splenomegaly or anemia |
| Assuming low/normal WBC count rules out serious infection | Clinicians expect high WBC in serious infection | Malaria typically causes leukopenia or normal WBC. Leukocytosis actually ARGUES AGAINST malaria and suggests bacterial superinfection |